The insulin-like growth factor (IGF) system comprises multiple growth factor receptors,
including insulin-like growth factor 1 receptor (IGF-1R), insulin receptor (IR)-A and-B. These …

Epigenetic dysregulation plays a crucial role in the development and progression of ovarian
cancer. Since the first experiment conducted on resistant ovarian cancer cells using …

In ovarian cancer (OVCA), treatment failure due to chemo-resistance is a serious challenge.
It is therefore critical to identify new therapies that are effective against resistant tumors and …

Lysosome-associated membrane protein 3 belongs to the lysosome-associated membrane
glycoprotein family, which is associated with lymph node, metastasis, poor overall survival …

The standard approach to treating patients with advanced epithelial ovarian cancer (EOC)
after primary debulking surgery remains taxane and platinum-based chemotherapy. Despite …

Background Despite prior attempts to evaluate the effects of sarcopenia on survival among
patients with gynecologic cancer, the results of these studies have not been consistent. The …

Objective BRCA mutations are the most frequent mutations causing homologous
recombination defects in epithelial ovarian cancers (EOC). Germline mutation carriers are …

Tumor necrosis factor‑α‑induced protein 8 (TNFAIP8) is an independent prognostic factor for
cancer‑specific and disease‑free survival in patients with epithelial ovarian cancer (EOC) …

Objective BRCA mutations have been associated with improved outcomes in ovarian cancer
patients. This study's objective was to compare the secondary cytoreduction surgery (SCS) …

Background: Epithelial ovarian cancer (EOC) is a disease with high morbidity and mortality
worldwide, which is seriously harmful to female health. LncRNA has an important …